(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BDC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BDC

ST13

US500000079189610

Class

5, 42

Filing

79189610

Registration

5225285

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

10/07/2024

Trademark type

Word

Nice classes

5, 42

Filing date

04/06/2016

Registration date

06/20/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/05/2024

Last transaction

01/05/2024

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

FALK,JONATHAN ROBERT

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Bicycletx Limited
Bicycle Therapeutics Limited

Representatives

Jacqueline P. Scheib Robinson & Cole LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productspharmaceutical preparations for use in oncologyboth solid and liquid tumoursmetabolic diseaseurology and renal diseasecardiovascularhaematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseaseinfectious diseaseboth bacterial and viralneurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics and clinical imaging agents

Class 42

Scientific and technological servicesscientific researchdiagnosis of disease and development of future human and veterinary medical treatments in the field of oncologyboth solid and liquid tumoursmetabolic diseaseurology and renal diseasecardiovascularhaematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseaseinfectious diseaseboth bacterial and viralneurological and psychiatric disordersdiagnostics and clinical imaging agents; industrial analysis and research services in the field of oncologyboth solid and liquid tumoursmetabolic diseaseurology and renal diseasecardiovascularhaematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseaseinfectious diseaseboth bacterial and viralneurological and psychiatric disordersdiagnostics and clinical imaging agents; informationconsultancy and advisory services relating to designplanning and implementation of scientific and clinical research for others

Publications

History of USPTO decisions and trademark events.

38 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

10/07/2024

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/12/2024

INPC

INVALIDATION PROCESSED

09/12/2024

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

09/06/2024

C71T

CANCELLED SECTION 71

01/05/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/01/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/24/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/20/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/17/2021

CHLD

CHANGE OF OWNER RECEIVED FROM IB

03/21/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/28/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/22/2017

FIMP

FINAL DISPOSITION PROCESSED

09/22/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/20/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/28/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/28/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

06/20/2017

PUBO

PUBLISHED FOR OPPOSITION

04/04/2017

GPNX

NOTIFICATION PROCESSED BY IB

04/01/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/15/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/15/2017

NPUB

NOTICE OF PUBLICATION

03/15/2017

CNEA

EXAMINERS AMENDMENT MAILED

02/27/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

02/24/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/24/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/03/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/02/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/02/2017

RFNT

REFUSAL PROCESSED BY IB

09/02/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/12/2016

RFRR

REFUSAL PROCESSED BY MPU

08/12/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/09/2016

MAFR

APPLICATION FILING RECEIPT MAILED

08/09/2016

CNRT

NON-FINAL ACTION WRITTEN

08/08/2016

DOCK

ASSIGNED TO EXAMINER

08/05/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/05/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/04/2016

Continuous trademark protection

Get notified about every new filing that threatens BDC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.